Walleye Capital
THC icon

Walleye Capital’s Tenet Healthcare THC Stock Holding History

Walleye Capital’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Buy
690
+603
+693% +$111K ﹤0.01% 3745
2026
Q1 		$16.4K Sell
87
-122,602
-100% -$25.8M ﹤0.01% 4102
2025
Q4 		$24.4M Sell
122,689
-20,590
-14% -$4.16M 0.07% 229
2025
Q3 		$29.1M Sell
143,279
-36,108
-20% -$6.41M 0.11% 148
2025
Q2 		$31.6M Buy
179,387
+64,925
+57% +$9.77M 0.12% 108
2025
Q1 		$15.4M Sell
114,462
-51,877
-31% -$6.83M 0.07% 280
2024
Q4 		$21M Buy
166,339
+22,731
+16% +$3.38M 0.05% 316
2024
Q3 		$23.9M Sell
143,608
-20,733
-13% -$3.14M 0.05% 276
2024
Q2 		$21.9M Buy
164,341
+33,996
+26% +$4.09M 0.04% 326
2024
Q1 		$13.7M Sell
130,345
-160,030
-55% -$14.4M 0.02% 626
2023
Q4 		$21.9M Buy
290,375
+115,162
+66% +$7.3M 0.05% 290
2023
Q3 		$11.5M Sell
175,213
-21,997
-11% -$1.64M 0.03% 488
2023
Q2 		$16M Sell
197,210
-37,718
-16% -$2.69M 0.06% 223
2023
Q1 		$14M Sell
234,928
-12,635
-5% -$702K 0.21% 92
2022
Q4 		$12.1M Buy
247,563
+5,001
+2% +$231K 0.22% 95
2022
Q3 		$12.5M Buy
242,562
+183,511
+311% +$10.9M 0.24% 80
2022
Q2 		$3.1M Sell
59,051
-51,283
-46% -$3.57M 0.09% 256
2022
Q1 		$9.48M Buy
110,334
+2,408
+2% +$198K 0.25% 81
2021
Q4 		$8.82M Buy
107,926
+13,382
+14% +$978K 0.27% 77
2021
Q3 		$6.28M Sell
94,544
-931
-1% -$66K 0.18% 64
2021
Q2 		$6.4M Buy
95,475
+25,033
+36% +$1.55M 0.22% 58
2021
Q1 		$3.66M Sell
70,442
-4,253
-6% -$215K 0.21% 74
2020
Q4 		$2.98M Buy
+74,695
New +$2.41M 0.2% 80
2020
Q1 		– Sell
-38,239
Closed -$1.45M – 1648
2019
Q4 		$1.45M Buy
+38,239
New +$1.15M 0.09% 289

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Walleye Capital's THC Position: Q2 2026 in Review

Walleye Capital increased its Tenet Healthcare (THC) stake by 693% in Q2 2026, buying an estimated $111K and bringing the position to 690 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #3745.

Walleye Capital first reported a position in THC in Q4 2019 and has held it in 24 quarters since. The position peaked at $31.6M in Q2 2025. 680 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Walleye Capital held 690 shares of Tenet Healthcare worth $129K as of Q2 2026.
  • Walleye Capital bought 603 Tenet Healthcare shares in Q2 2026, an estimated $111K.
  • Tenet Healthcare made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3745 holding.
  • Walleye Capital first reported a position in Tenet Healthcare in Q4 2019 and has held it in 24 quarters since.
  • Walleye Capital's Tenet Healthcare position peaked at $31.6M in Q2 2025.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.